Evidence map›Paper›PMID 41492108›Full record

ArticleeLife2026

Heterogeneity of genetic sequence within quasi-species of influenza virus revealed by single-molecule sequencing.

Kenji Tamao, Hiroyuki Noji, Kazuhito Tabata

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kenji TamaoDepartment of Applied Chemistry, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0009-0009-0297-6107
Hiroyuki NojiDepartment of Applied Chemistry, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-8842-6836
Kazuhito TabataDepartment of Applied Chemistry, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0463-1374

Funding

Japan Agency for Medical Research and Development JP223fa627001Japan Science and Technology Agency 10.52926/jpmjcr22n2
6 · The paper itself

Abstract

Influenza viruses exhibit high mutation rates and extensive genetic diversity, which hinder effective vaccine development and facilitate immune evasion (Taubenberger and Morens, 2006; Barr et al., 2010). These mutations arise from the error-prone viral RNA-dependent RNA polymerase, generating highly heterogeneous viral populations within individual hosts that conform to the quasi-species model of a cloud of related genomes evolving under selection (Domingo et al., 2012). Accurate characterization of this intra-host diversity is crucial for understanding viral evolution and improving vaccine design, yet conventional RNA sequencing often fails to detect low-frequency variants because of technical errors during sample preparation and sequencing. Here, we implement a single unique molecular identifier strategy that reduces sequencing artifacts and achieves an error rate of ~10⁻⁵, enabling single-particle-level quantification of quasi-species diversity. Mutation frequencies greatly exceeding background error confirm their biological origin, while information-theoretic metrics such as Shannon entropy and Jensen-Shannon divergence reveal non-random mutation distributions under selective constraints. This framework supports detailed studies of intra-host viral evolution and may inform artificial intelligence-driven prediction of mutational trajectories and more effective influenza vaccine strategies.

Indexed as

Genetic HeterogeneityGenetic VariationOrthomyxoviridaeQuasispeciesEvolution, MolecularHumansgenetic heterogeneityinfectious diseasemicrobiologyquasispeciessingle-molecule sequencingUMIsunique molecular identifiersviral evolutionviruses

Identifiers

PMID41492108
PMCPMC12774415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.